VNU to buy IMS Health for $7B

Dutch media giant VNU is buying IMS Health for $7 billion in cash and stock. VNU believes that adding IMS -- a leading provider of pharmaceutical and healthcare information on product use -- will be a good fit with its Nielsen ratings and analysis of consumer packaged goods. Analysts, however, weren't quick to agree, with some noting that IMS may not have all that much available to cut. VNU is paying $11.25 per share, a 16 percent premium over the stock's average trading price over the past 30 days.

- read this story from USA Today

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.